NCT02933892CompletedPhase 4
Benefit of Transradial Approach in Chronic Kidney Disease Population Undergoing Cardiac Catheterization
Benefit of Transradial Approach in Chronic Kidney Disease Population Undergoing Cardiac Catheterization, A Single Center Randomized Controlled Trial
Source: ClinicalTrials.gov · Last updated 6 Nov 2024
Brief summary (registry, in English)
The investigators will conduct a randomized controlled trial that aims to compare the incidence of contrast-induced nephropathy between transradial- and transfemoral-access cardiac catheterization.
- Status (registry)
- Completed
- Phase (registry)
- Phase 4
- Study type
- Interventional
- Enrollment
- 39 (actual)
- First submitted
- 12 Oct 2016
- Start date
- Oct 2016
- Primary completion date
- 30 Aug 2024
- Lead sponsor
- Texas Tech University Health Sciences Center
- Diseases
- Chronic kidney disease
- NCT number
- NCT02933892
What you commit to
- Study type: Interventional · Phase 4
- Participants enrolled: 39
- From Oct 2016 to the primary completion date, 30 Aug 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients who have previously undergone a coronary artery bypass graft procedure.
- Patients with prior catheterization within the last 5 years.
- Contrast used within the previous 3 weeks.
Other illness
- Patients with a history of cardiogenic shock.
- Any condition preventing TRA or TFA access.
- Allergy to contrast dye.
Age
- Children (under the age of 18).
Other
- Women who are pregnant or expect to become pregnant. Pregnancy tests for women of childbearing potential (WOCHP) will be performed as standard of care.
- Medical, geographical, or social factors making study participation impractical, i.e. documented noncompliance, unable to return for follow-ups and lab draws, etc.
- A positive Allen's Test on the right radial artery.
- Inability to successfully access the artery randomized to use.
Who the study is looking for
- Patients scheduled to undergo non-emergent cardiac catheterization at University Medical Center Hospital, Lubbock, TX from January 2016 to January 2018. Emergent cardiac catheterizations will be defined as a catheterization scheduled \< 24 hours from a cardiac event.
- Patients willing to be randomized to TFA or TRA procedure.
- Patients signed and dated the informed consent agreeing to participate in the study.
- Patients with chronic kidney disease, defined as eGFR = 15-59mL/min defined by the MDRD formula. (eGFR is a standard of care measurement for all patients undergoing coronary intervention.).
- Patients ages 18-88 years old.
Age in the registry: 18 years to 88 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Texas Tech University Health Sciences Center Coordinator of this site? Confirm its status | Lubbock | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.